These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 14695138

  • 1. Interleukin-13 receptor alpha2 chain in human head and neck cancer serves as a unique diagnostic marker.
    Kawakami M, Kawakami K, Kasperbauer JL, Hinkley LL, Tsukuda M, Strome SE, Puri RK.
    Clin Cancer Res; 2003 Dec 15; 9(17):6381-8. PubMed ID: 14695138
    [Abstract] [Full Text] [Related]

  • 2. Interleukin-13 receptor alpha2 chain: a potential biomarker and molecular target for ovarian cancer therapy.
    Kioi M, Kawakami M, Shimamura T, Husain SR, Puri RK.
    Cancer; 2006 Sep 15; 107(6):1407-18. PubMed ID: 16902988
    [Abstract] [Full Text] [Related]

  • 3. Analysis of interleukin-13 receptor alpha2 expression in human pediatric brain tumors.
    Kawakami M, Kawakami K, Takahashi S, Abe M, Puri RK.
    Cancer; 2004 Sep 01; 101(5):1036-42. PubMed ID: 15329913
    [Abstract] [Full Text] [Related]

  • 4. Growth stimulation of human head and neck squamous cell carcinoma cell lines by interleukin 4.
    Myers JN, Yasumura S, Suminami Y, Hirabayashi H, Lin Wc, Johnson JT, Lotze MT, Whiteside TL.
    Clin Cancer Res; 1996 Jan 01; 2(1):127-35. PubMed ID: 9816099
    [Abstract] [Full Text] [Related]

  • 5. Heterogeneity in interleukin-13 receptor expression and subunit structure in squamous cell carcinoma of head and neck: differential sensitivity to chimeric fusion proteins comprised of interleukin-13 and a mutated form of Pseudomonas exotoxin.
    Joshi BH, Kawakami K, Leland P, Puri RK.
    Clin Cancer Res; 2002 Jun 01; 8(6):1948-56. PubMed ID: 12060640
    [Abstract] [Full Text] [Related]

  • 6. Expression and structure of interleukin 4 receptors in primary meningeal tumors.
    Puri S, Joshi BH, Sarkar C, Mahapatra AK, Hussain E, Sinha S.
    Cancer; 2005 May 15; 103(10):2132-42. PubMed ID: 15830341
    [Abstract] [Full Text] [Related]

  • 7. Surface membrane-expressed CD40 is present on tumor cells from squamous cell cancer of the head and neck in vitro and in vivo and regulates cell growth in tumor cell lines.
    Posner MR, Cavacini LA, Upton MP, Tillman KC, Gornstein ER, Norris CM.
    Clin Cancer Res; 1999 Aug 15; 5(8):2261-70. PubMed ID: 10473114
    [Abstract] [Full Text] [Related]

  • 8. The interleukin-4/interleukin-13 receptor of human synovial fibroblasts: overexpression of the nonsignaling interleukin-13 receptor alpha2.
    Feng N, Lugli SM, Schnyder B, Gauchat JF, Graber P, Schlagenhauf E, Schnarr B, Wiederkehr-Adam M, Duschl A, Heim MH, Lutz RA, Moser R.
    Lab Invest; 1998 May 15; 78(5):591-602. PubMed ID: 9605184
    [Abstract] [Full Text] [Related]

  • 9. Correlation of protease-activated receptor-1 with differentiation markers in squamous cell carcinoma of the head and neck and its implication in lymph node metastasis.
    Zhang X, Hunt JL, Landsittel DP, Muller S, Adler-Storthz K, Ferris RL, Shin DM, Chen ZG.
    Clin Cancer Res; 2004 Dec 15; 10(24):8451-9. PubMed ID: 15625067
    [Abstract] [Full Text] [Related]

  • 10. Interleukin-13 receptor alpha chain: a novel tumor-associated transmembrane protein in primary explants of human malignant gliomas.
    Joshi BH, Plautz GE, Puri RK.
    Cancer Res; 2000 Mar 01; 60(5):1168-72. PubMed ID: 10728667
    [Abstract] [Full Text] [Related]

  • 11. Structure, function, and targeting of interleukin 4 receptors on human head and neck cancer cells.
    Kawakami K, Leland P, Puri RK.
    Cancer Res; 2000 Jun 01; 60(11):2981-7. PubMed ID: 10850446
    [Abstract] [Full Text] [Related]

  • 12. Role of interleukin-13 in cancer, pulmonary fibrosis, and other T(H)2-type diseases.
    Joshi BH, Hogaboam C, Dover P, Husain SR, Puri RK.
    Vitam Horm; 2006 Jun 01; 74():479-504. PubMed ID: 17027527
    [Abstract] [Full Text] [Related]

  • 13. Interleukin 4 receptor-directed cytotoxin therapy for human head and neck squamous cell carcinoma in animal models.
    Strome SE, Kawakami K, Alejandro D, Voss S, Kasperbauer JL, Salomao D, Chen L, Maki RA, Puri RK.
    Clin Cancer Res; 2002 Jan 01; 8(1):281-6. PubMed ID: 11801570
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. In situ expression of interleukin-4 (IL-4) receptors in human brain tumors and cytotoxicity of a recombinant IL-4 cytotoxin in primary glioblastoma cell cultures.
    Joshi BH, Leland P, Asher A, Prayson RA, Varricchio F, Puri RK.
    Cancer Res; 2001 Nov 15; 61(22):8058-61. PubMed ID: 11719427
    [Abstract] [Full Text] [Related]

  • 17. Potent antitumor activity of IL-13 cytotoxin in human pancreatic tumors engineered to express IL-13 receptor alpha2 chain in vivo.
    Kawakami K, Kawakami M, Husain SR, Puri RK.
    Gene Ther; 2003 Jul 15; 10(13):1116-28. PubMed ID: 12808442
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer.
    Grandis JR, Tweardy DJ.
    Cancer Res; 1993 Aug 01; 53(15):3579-84. PubMed ID: 8339264
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.